5C8-27501-96588
3 vaccinations
4 coded responses
34 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 731 / OK
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
- 2020-12-20
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-27
- 2021-01-03
-
2021-01-10
Dose 2 — Pfizer-BioNTech
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-24
-
2021-01-31
Survey response — day 21, dose 2MedDRA: Mastitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MastitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-01
Call successfulCompleted over the phone
-
2021-02-07
Survey response — day 28, dose 2MedDRA: Preterm premature rupture of membranes — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: Preterm Premature rupture of membranesbirth of baby at 35.6 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-14
- 2021-02-21
- 2021-02-26
- 2021-03-01
- 2021-04-11
- 2021-07-11
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-06
-
2021-10-11
Survey response — day 14, dose 3MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Cough, runny nose, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Sinusitis — Feeling: FairFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-11 | Successful | Completed over the phone |
| 2021-01-31 | Successful 2021-02-01 |
Completed over the phone |
| 2021-02-07 | Unsuccessful | Reported to VAERS during previous contact from GDIT |
Free text
Release 3 — day 21, dose 2
Symptoms: Mastitis
Release 3 — day 28, dose 2
Symptoms: Preterm Premature rupture of membranesbirth of baby at 35.6 weeks
Release 10 — day 14, dose 3
Symptoms: Cough, runny nose, sore throat
Release 12 — 12 months, dose 3
Symptoms: Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Mastitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Preterm premature rupture of membranes | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release